Product correctly added to cart.

5-Methyl-1,3-dihydro-2H-indol-2-one
View 3D

Biosynth logo

5-Methyl-1,3-dihydro-2H-indol-2-one

CAS: 3484-35-3

Ref. 3D-FM51621

1gDiscontinued
2gDiscontinued
100mgDiscontinued
250mgDiscontinued
500mgDiscontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
5-Methyl-1,3-dihydro-2H-indol-2-one
Synonyms:
  • 5-Methyl-1,3-dihydro-indol-2-one5-Methylindolin-2-one
  • 1,3-Dihydro-5-methyl-2H-indol-2-one
  • 2-Indolinone, 5-methyl-
  • 2H-Indol-2-one, 1,3-dihydro-5-methyl-
  • 5-Methyl-2-indolinone
  • 5-Methyl-2-oxindole
  • 5-Methyl-2-oxoindoline
  • 5-Methyloxindole
  • 5-methyl-1,3-dihydro-2H-indol-2-one
  • Oxindole, 5-methyl-
  • See more synonyms
Description:

5-Methyl-1,3-dihydro-2H-indol-2-one is a chiral compound that has been shown to have antitumor activity. It was synthesized by reacting aluminium with oxindole in vivo and had a reaction time of 45 minutes. The enantiomers of 5-Methyl-1,3-dihydro-2H-indol-2-one were separated by chromatography on silica gel column and showed potent cytotoxicity against cancer cells. The two enantiomers were found to be stereospecific, as they only inhibited the growth of one type of cancer cell line.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
147.17 g/mol
Formula:
C9H9NO
Purity:
Min. 95%
InChI:
InChI=1S/C9H9NO/c1-6-2-3-8-7(4-6)5-9(11)10-8/h2-4H,5H2,1H3,(H,10,11)
InChI key:
InChIKey=HXQDSHSATAEREW-UHFFFAOYSA-N
SMILES:
Cc1ccc2c(c1)CC(=O)N2
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: 3D-FM51621 5-Methyl-1,3-dihydro-2H-indol-2-one

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".